BR9914688A - Compostos de pirano, piperidino e tiopirano e seus métodos de uso - Google Patents
Compostos de pirano, piperidino e tiopirano e seus métodos de usoInfo
- Publication number
- BR9914688A BR9914688A BR9914688-6A BR9914688A BR9914688A BR 9914688 A BR9914688 A BR 9914688A BR 9914688 A BR9914688 A BR 9914688A BR 9914688 A BR9914688 A BR 9914688A
- Authority
- BR
- Brazil
- Prior art keywords
- piperidine
- methods
- pyran
- compounds
- thiopyran compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
Abstract
"COMPOSTOS DE PIRANO, PIPERIDINO E TIOPIRANO E SEUS MéTODOS DE USO" A presente invenção provê novos compostos de fórmula (I) que podem ser úteis em hiper-polarização de membranas de células, abertura de canais de potássio, relaxamento de células de músculo liso, e inibição de contrações de bexiga.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18169098A | 1998-10-28 | 1998-10-28 | |
US09/421,862 US6191140B1 (en) | 1998-10-28 | 1999-10-20 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
PCT/US1999/025373 WO2000024743A1 (en) | 1998-10-28 | 1999-10-28 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9914688A true BR9914688A (pt) | 2001-10-02 |
Family
ID=26877422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9914688-6A BR9914688A (pt) | 1998-10-28 | 1999-10-28 | Compostos de pirano, piperidino e tiopirano e seus métodos de uso |
Country Status (21)
Country | Link |
---|---|
US (1) | US6191140B1 (pt) |
EP (1) | EP1124828B1 (pt) |
JP (1) | JP2002528454A (pt) |
KR (1) | KR20010085975A (pt) |
CN (1) | CN1335846A (pt) |
AT (1) | ATE382620T1 (pt) |
AU (1) | AU764163B2 (pt) |
BG (1) | BG105524A (pt) |
BR (1) | BR9914688A (pt) |
CA (1) | CA2348576A1 (pt) |
CZ (1) | CZ20011480A3 (pt) |
DE (1) | DE69937895T2 (pt) |
ES (1) | ES2299272T3 (pt) |
HK (1) | HK1041877A1 (pt) |
HU (1) | HUP0104146A3 (pt) |
NO (1) | NO318628B1 (pt) |
NZ (1) | NZ511041A (pt) |
PL (1) | PL347552A1 (pt) |
SK (1) | SK5242001A3 (pt) |
TR (1) | TR200101140T2 (pt) |
WO (1) | WO2000024743A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
US6642222B2 (en) * | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
ES2292462T3 (es) * | 1999-08-03 | 2008-03-16 | Abbott Laboratories | Agentes abridores de los canales del potasio. |
US6538004B2 (en) * | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
EP1307429B1 (en) | 2000-08-02 | 2007-11-28 | AstraZeneca AB | Process for asymmetric synthesis of substituted 1,4-dihydropyridines |
US6632418B2 (en) * | 2001-07-30 | 2003-10-14 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
WO2003011869A1 (en) * | 2001-07-30 | 2003-02-13 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
US20030153773A1 (en) * | 2002-02-14 | 2003-08-14 | Wayne Gregory S. | Process for the production of dihydropyridines |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321384A (en) | 1981-02-27 | 1982-03-23 | American Home Products Corporation | Antihypertensive agents |
EP0059291B1 (en) | 1981-02-27 | 1985-03-27 | American Home Products Corporation | Antihypertensive agents |
US4551534A (en) | 1984-03-30 | 1985-11-05 | American Home Products Corporation | Aralkyl or aryloxyalkyl 1,7-naphthyridine-3-carboxylic acid esters |
AU6042686A (en) | 1985-07-29 | 1987-02-05 | American Home Products Corporation | 1,4,5,6,7,8-hexahydro-(substituted) phenyl-1,7- napthyridine-3-carboxylic acid derivatives |
US4618678A (en) | 1985-07-29 | 1986-10-21 | American Home Products Corporation | 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester |
US4596873A (en) | 1985-07-29 | 1986-06-24 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridine-3-carboxylic acid aromatic esters and pharmaceutically acceptable acid addition salts thereof useful as antihypertensive agents |
ATE161531T1 (de) | 1991-10-21 | 1998-01-15 | Zeneca Ltd | Acridine-1,8-dionderivate als therapeutisches mittel |
GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
DE4424678A1 (de) | 1994-07-13 | 1996-01-18 | Bayer Ag | Dioxo-thiopyrano-pyridin-carbonsäure-derivate |
TR200001715T2 (tr) | 1997-12-18 | 2000-12-21 | Abbott Laboratories | Potasyum kanalı açıcıları. |
US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
CA2348165A1 (en) * | 1998-10-28 | 2000-05-04 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
-
1999
- 1999-10-20 US US09/421,862 patent/US6191140B1/en not_active Expired - Fee Related
- 1999-10-28 HU HU0104146A patent/HUP0104146A3/hu unknown
- 1999-10-28 AT AT99960168T patent/ATE382620T1/de not_active IP Right Cessation
- 1999-10-28 KR KR1020017005347A patent/KR20010085975A/ko not_active Application Discontinuation
- 1999-10-28 CZ CZ20011480A patent/CZ20011480A3/cs unknown
- 1999-10-28 PL PL99347552A patent/PL347552A1/xx not_active Application Discontinuation
- 1999-10-28 DE DE69937895T patent/DE69937895T2/de not_active Expired - Lifetime
- 1999-10-28 EP EP99960168A patent/EP1124828B1/en not_active Expired - Lifetime
- 1999-10-28 JP JP2000578313A patent/JP2002528454A/ja active Pending
- 1999-10-28 ES ES99960168T patent/ES2299272T3/es not_active Expired - Lifetime
- 1999-10-28 CA CA002348576A patent/CA2348576A1/en not_active Abandoned
- 1999-10-28 CN CN99815020A patent/CN1335846A/zh active Pending
- 1999-10-28 BR BR9914688-6A patent/BR9914688A/pt not_active IP Right Cessation
- 1999-10-28 TR TR2001/01140T patent/TR200101140T2/xx unknown
- 1999-10-28 WO PCT/US1999/025373 patent/WO2000024743A1/en active IP Right Grant
- 1999-10-28 SK SK524-2001A patent/SK5242001A3/sk unknown
- 1999-10-28 NZ NZ511041A patent/NZ511041A/xx unknown
- 1999-10-28 AU AU17095/00A patent/AU764163B2/en not_active Ceased
-
2001
- 2001-04-27 NO NO20012100A patent/NO318628B1/no not_active IP Right Cessation
- 2001-05-19 BG BG105524A patent/BG105524A/bg unknown
-
2002
- 2002-02-19 HK HK02101208.4A patent/HK1041877A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DE69937895D1 (de) | 2008-02-14 |
SK5242001A3 (en) | 2001-12-03 |
ES2299272T3 (es) | 2008-05-16 |
EP1124828A1 (en) | 2001-08-22 |
ATE382620T1 (de) | 2008-01-15 |
NZ511041A (en) | 2003-03-28 |
KR20010085975A (ko) | 2001-09-07 |
NO318628B1 (no) | 2005-04-18 |
AU1709500A (en) | 2000-05-15 |
WO2000024743A1 (en) | 2000-05-04 |
EP1124828B1 (en) | 2008-01-02 |
NO20012100L (no) | 2001-06-14 |
CN1335846A (zh) | 2002-02-13 |
NO20012100D0 (no) | 2001-04-27 |
DE69937895T2 (de) | 2009-01-02 |
HUP0104146A3 (en) | 2002-10-28 |
HUP0104146A2 (hu) | 2002-04-29 |
HK1041877A1 (zh) | 2002-07-26 |
CZ20011480A3 (cs) | 2001-08-15 |
BG105524A (bg) | 2001-12-29 |
TR200101140T2 (tr) | 2002-07-22 |
AU764163B2 (en) | 2003-08-14 |
PL347552A1 (en) | 2002-04-08 |
JP2002528454A (ja) | 2002-09-03 |
US6191140B1 (en) | 2001-02-20 |
CA2348576A1 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102800T2 (tr) | Yeni bileşikler. | |
TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
YU47204B (sh) | Derivati didehidro-vitamina d3 | |
TR200002191T2 (tr) | Potasyum kanal önleyicileri | |
DK0697859T3 (da) | Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH | |
PA8467101A1 (es) | Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orli | |
PT799058E (pt) | Melhoramentos na funcao endometrica ou com ela relacionados | |
ATE283388T1 (de) | Sicherheitspapier | |
BR9914688A (pt) | Compostos de pirano, piperidino e tiopirano e seus métodos de uso | |
TR199900154T2 (xx) | Tienopiridin t�revi i�eren antitrombotik ve antiaterojenik farmas�tik kompozisyon | |
DE60019121D1 (de) | Kaliumkanäleöffner | |
CA2322689A1 (en) | Substituted bisindolymaleimides for the inhibition of cell proliferation | |
DK1204659T3 (da) | Serotonerge benzofuraner | |
TR199901386T2 (en) | �midazopiridazinler. | |
CY1105765T1 (el) | Πυρανο πιπepιδιο και θειοπυρανο ενωσεις και μεθοδοι χρησης | |
CA2216583A1 (en) | Levobupivacaine and its use as an anaesthetic in pregnant women | |
IT1299161B1 (it) | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph | |
GB2324091A (en) | Metalloproteinase inhibitors | |
CA2168192A1 (en) | 4-aminobenzoylguanidine derivatives | |
TR200202439T2 (tr) | Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1) | |
FI972336A0 (fi) | Biotiinin lisääntynyt biosynteesi kasvisolukossa | |
WO2002065606A3 (en) | Energy pathway arrangements for energy conditioning | |
TR199901535A2 (en) | Siklooksigenaz �nleyicisi. | |
CH686599GA3 (fr) | Piece d'horlogerie alimentee par des cellules solaires. | |
DE50106936D1 (de) | Lösung zur Konservierung menschlicher Leberzellen, konservierte Leberzelle, und ihre Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1947 DE 29 - 04 - 2008. |